Can I submit a Sequence Listing in XML format for applications filed before September 16, 2012?
Can I submit a Sequence Listing in XML format for applications filed before September 16, 2012? Yes, you can submit a Sequence Listing in XML format for applications filed before September 16, 2012, even though it’s not mandatory. According to MPEP 2415.01: “For applications filed prior to September 16, 2012, a Sequence Listing in XML…
Read MoreWhat is the difference between WIPO Standard ST.25 and ST.26 for Sequence Listings?
WIPO Standard ST.25 and ST.26 are two different formats for submitting Sequence Listings in patent applications. The key differences are: ST.25 is the older format, used for applications filed before July 1, 2022. ST.26 is the new XML-based format, required for applications filed on or after July 1, 2022. The MPEP explains the transition: “Though…
Read MoreHow does the ST.26 Standard affect Sequence Listing submissions?
How does the ST.26 Standard affect Sequence Listing submissions? The ST.26 Standard, as mentioned in MPEP 2415.01, has significantly impacted Sequence Listing submissions: It requires all Sequence Listings to be in XML format It applies to applications filed on or after July 1, 2022 It affects both national and international applications The MPEP states: “For…
Read MoreWhat is the difference between ST.25 and ST.26 for Sequence Listings?
What is the difference between ST.25 and ST.26 for Sequence Listings? The main differences between ST.25 and ST.26 for Sequence Listings, as implied in MPEP 2415.01, are: Format: ST.25 used a text-based format, while ST.26 requires XML format Application Date: ST.25 applied to applications filed before July 1, 2022, while ST.26 applies to applications filed…
Read MoreAre reissue applications subject to the Sequence Listing XML requirement?
Yes, reissue applications filed on or after July 1, 2022, are subject to the Sequence Listing XML requirement if they contain nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(a) or (b). The MPEP clarifies: “Compliance with 37 CFR 1.831 through 1.835 (rules based on WIPO Standard ST.26) is also applicable to any…
Read MoreHow does the Sequence Listing XML requirement affect applications claiming priority to earlier filings?
Applications filed on or after July 1, 2022, that claim benefit or priority to earlier applications must still comply with the new Sequence Listing XML requirement, regardless of the format used in the prior application. The MPEP clarifies: “If a prior application to which benefit or priority is claimed contains a ‘Sequence Listing’ in Standard…
Read MoreWhen is a Sequence Listing in XML format required for patent applications?
A Sequence Listing in XML format is required for patent applications filed on or after July 1, 2022, that disclose nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). The MPEP states: “An application that has a filing date on or after July 1, 2022, will be required to provide a ‘Sequence Listing…
Read MoreDoes the Sequence Listing XML requirement apply to international applications entering the national stage?
Yes, the Sequence Listing XML requirement applies to international applications entering the national stage based on their international filing date. The MPEP states: “As provided in 35 U.S.C. 363, the filing date of an international stage application is also the filing date for the national stage application filed under 35 U.S.C. 371. Accordingly, for applications…
Read MoreWhat are the requirements for submitting a Sequence Listing in XML format?
What are the requirements for submitting a Sequence Listing in XML format? According to MPEP 2415.01, a Sequence Listing in XML format must be submitted when: An application discloses nucleotide and/or amino acid sequences that must be included in a “Sequence Listing” The application is filed on or after July 1, 2022 The MPEP states:…
Read MoreHow does the Patent Law Treaties Implementation Act (PLTIA) affect Sequence Listing requirements?
How does the Patent Law Treaties Implementation Act (PLTIA) affect Sequence Listing requirements? The Patent Law Treaties Implementation Act (PLTIA) has significantly impacted Sequence Listing requirements for patent applications. According to MPEP 2415.01: “For applications filed on or after September 16, 2012, the PLTIA amended 35 U.S.C. 112(a) to require the specification to contain a…
Read More